AAAAAA

   
Results: 1-25 | 26-50 | 51-57
Results: 26-50/57
Strategies for immunotherapy of cancer
Authors: Melief, CJM Toes, REM Medema, JP Van der Burg, SH Ossendorp, F Offringa, R
Citation: Cjm. Melief et al., Strategies for immunotherapy of cancer, ADV IMMUNOL, 75, 2000, pp. 235-282
Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin
Authors: van Hall, T van Bergen, J van Veelen, PA Kraakman, M Henkamp, LC Koning, F Melief, CJM Ossendorp, F Offringa, R
Citation: T. Van Hall et al., Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin, J IMMUNOL, 165(2), 2000, pp. 869-877
Adaptive T cell immunotherapy of human uveal melanoma targeting gp100
Authors: Sutmuller, RPM Schurmans, LRHM van Duivenvoorde, LM Tine, JA van der Voort, EIH Toes, REM Melief, CJM Jager, MJ Offringa, R
Citation: Rpm. Sutmuller et al., Adaptive T cell immunotherapy of human uveal melanoma targeting gp100, J IMMUNOL, 165(12), 2000, pp. 7308-7315
MHC class I antigen processing of an Adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells
Authors: Sijts, AJAM Standera, S Toes, REM Ruppert, T Beekman, NJCM van Veelen, PA Ossendorp, FA Melief, CJM Kloetzel, PM
Citation: Ajam. Sijts et al., MHC class I antigen processing of an Adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells, J IMMUNOL, 164(9), 2000, pp. 4500-4506
Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli
Authors: Schuurhuis, DH Laban, S Toes, REM Ricciardi-Castagnoli, P Kleijmeer, MJ van der Voort, EIH Rea, D Offringa, R Geuze, HJ Melief, CJM Ossendorp, F
Citation: Dh. Schuurhuis et al., Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli, J EXP MED, 192(1), 2000, pp. 145-150
Cyclophosphamide enhances anti-tubor effect of wild-type p53-specific CTL
Authors: Vierboom, MPM Bos, GMJ Ooms, M Offringa, R Melief, CJM
Citation: Mpm. Vierboom et al., Cyclophosphamide enhances anti-tubor effect of wild-type p53-specific CTL, INT J CANC, 87(2), 2000, pp. 253-260
Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide
Authors: van Bergen, J Camps, M Offringa, R Melief, CJM Ossendorp, F Koning, F
Citation: J. Van Bergen et al., Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide, CANCER RES, 60(22), 2000, pp. 6427-6433
High steady-state levels of p53 are not a prerequisite for tumor eradication by wild-type p53-specific cytotoxic T lymphocytes
Authors: Vierboom, MPM Zwaveling, S Bos, GMJ Ooms, M Krietemeijer, GM Melief, CJM Offringa, R
Citation: Mpm. Vierboom et al., High steady-state levels of p53 are not a prerequisite for tumor eradication by wild-type p53-specific cytotoxic T lymphocytes, CANCER RES, 60(19), 2000, pp. 5508-5513
Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10
Authors: Rea, D van Kooten, G van Meijgaarden, KE Ottenhoff, THM Melief, CJM Offringa, R
Citation: D. Rea et al., Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10, BLOOD, 95(10), 2000, pp. 3162-3167
p53: A target for T-cell mediated immunotherapy
Authors: Vierboom, MPM Gabrilovich, DI Offringa, R Kast, WM Melief, CJM
Citation: Mpm. Vierboom et al., p53: A target for T-cell mediated immunotherapy, MED INTEL U, 24, 2000, pp. 40-55
Peptides in cervical cancer
Authors: Ressing, ME Brandt, RMP de Jong, JH Offringa, R Melief, CJM Kast, WM
Citation: Me. Ressing et al., Peptides in cervical cancer, MED INTEL U, 24, 2000, pp. 172-189
The BCR-ABL oncoprotein and immunological targeting - Vaccination for tumor prevention and therapy
Authors: ten Bosch, GJA Leeksma, OC Melief, CJM
Citation: Gja. Ten Bosch et al., The BCR-ABL oncoprotein and immunological targeting - Vaccination for tumor prevention and therapy, BAS CLIN ON, 22, 2000, pp. 369-378
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
Authors: Diehl, L den Boer, AT Schoenberger, SP van der Voort, EIH Schumacher, TNM Melief, CJM Offringa, R Toes, REM
Citation: L. Diehl et al., CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy, NAT MED, 5(7), 1999, pp. 774-779
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: Clinical evaluation of a phase I-II trial
Authors: van Driel, WJ Ressing, ME Kenter, GG Brandt, RMP Krul, EJT van Rossum, AB Schuuring, E Offringa, R Bauknecht, T Tamm-Hermelink, A van Dam, PA Fleuren, GJ Kast, WM Melief, CJM Trimbos, JB
Citation: Wj. Van Driel et al., Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: Clinical evaluation of a phase I-II trial, EUR J CANC, 35(6), 1999, pp. 946-952
Immunotherapeutic strategies for cervical squamous carcinoma
Authors: van Driel, WJ Kenter, GG Fleuren, GJ Melief, CJM Trimbos, BJ
Citation: Wj. Van Driel et al., Immunotherapeutic strategies for cervical squamous carcinoma, HEMAT ONCOL, 13(1), 1999, pp. 259
Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer
Authors: Nijman, HW Kenemans, P Poort-Keesom, RJJ Verstraeten, RA Mensdorff-Pouilly, S Verheijen, RHM Melief, CJM Hilgers, J Meijer, CJLM
Citation: Hw. Nijman et al., Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer, EUR J OB GY, 83(2), 1999, pp. 201-206
HLA and susceptibility to cervical neoplasia
Authors: Krul, EJT Schipper, RF Schrueder, GMT Fleuren, GJ Kenter, GG Melief, CJM
Citation: Ejt. Krul et al., HLA and susceptibility to cervical neoplasia, HUMAN IMMUN, 60(4), 1999, pp. 337-342
Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset
Authors: Rea, D Schagen, FHE Hoeben, RC Mehtali, M Havenga, MJE Toes, REM Melief, CJM Offringa, R
Citation: D. Rea et al., Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset, J VIROLOGY, 73(12), 1999, pp. 10245-10253
Polyriboinosinic polyribocytidylic acid (poly(I : C)) induces stable maturation of functionally active human dendritic cells
Authors: Verdijk, RM Mutis, T Esendam, B Kamp, J Melief, CJM Brand, A Goulmy, E
Citation: Rm. Verdijk et al., Polyriboinosinic polyribocytidylic acid (poly(I : C)) induces stable maturation of functionally active human dendritic cells, J IMMUNOL, 163(1), 1999, pp. 57-61
Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4(+) T cells by at least four unrelated HLA-DR molecules
Authors: van der Burg, SH Kwappenberg, KMC Geluk, A van der Kruk, M Pontesilli, O Hovenkamp, E Franken, KLMC van Meijgaarden, KE Drijfhout, JW Ottenhoff, THM Melief, CJM Offringa, R
Citation: Sh. Van Der Burg et al., Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4(+) T cells by at least four unrelated HLA-DR molecules, J IMMUNOL, 162(1), 1999, pp. 152-160
Immune escape of tumors in vivo by expression of cellular FLICE-inhibitoryprotein
Authors: Medema, JP de Jong, J van Hall, T Melief, CJM Offringa, R
Citation: Jp. Medema et al., Immune escape of tumors in vivo by expression of cellular FLICE-inhibitoryprotein, J EXP MED, 190(7), 1999, pp. 1033-1038
Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition
Authors: Kammer, AR van der Burg, SH Grabscheid, B Hunziker, IP Kwappenberg, KMC Reichen, J Melief, CJM Cerny, A
Citation: Ar. Kammer et al., Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition, J EXP MED, 190(2), 1999, pp. 169-176
CD4 T cells and their role in antitumor immune responses
Authors: Toes, REM Ossendorp, F Offringa, R Melief, CJM
Citation: Rem. Toes et al., CD4 T cells and their role in antitumor immune responses, J EXP MED, 189(5), 1999, pp. 753-756
Differential binding of viral peptides to HLA-A2 alleles. Implications forhuman papillomavirus type 16 E7 peptide-based vaccination against cervicalcarcinoma
Authors: Ressing, ME de Jong, JH Brandt, RMP Drijfhout, JW Benckhuijsen, WE Schreuder, GMT Offringa, R Kast, WM Melief, CJM
Citation: Me. Ressing et al., Differential binding of viral peptides to HLA-A2 alleles. Implications forhuman papillomavirus type 16 E7 peptide-based vaccination against cervicalcarcinoma, EUR J IMMUN, 29(4), 1999, pp. 1292-1303
Successful immunotherapy of an intraocular tumor in mice
Authors: Schurmans, LRHM den Boer, AT Diehl, L van der Voort, EIH Kast, WM Melief, CJM Toes, REM Jager, MJ
Citation: Lrhm. Schurmans et al., Successful immunotherapy of an intraocular tumor in mice, CANCER RES, 59(20), 1999, pp. 5250-5254
Risultati: 1-25 | 26-50 | 51-57